microenvironment adopt a protumoral phenotype at both primary

microenvironment is in an
immunosuppressive state where the suppressed immune cells benefit the tumour by
promoting angiogenesis, tumour survival and metastasis.   After
the monocytes are actively recruited into tumours along defined chemotactic
gradients which are  chemotactic ligands
that create chemical concentration gradients that organisms move towards or
away  , they reside and differentiate
into  tumour-associated macrophages ( TAMs)
. TAMs constitute the major portion of the immune cells in the tumour stroma. TAMs
appear to be preferentially attracted to and retained in areas of necrosis (unprogrammed cell death caused due to external factors such
as infection,trauma and unregulated digestion of cellular components),  and hypoxia ( deficiency of oxygen reaching
the tissues) where they become phenotypically altered and upregulate
hypoxia-induced transcription factors. TAMs rather than being tumoricidal also
adopt a protumoral phenotype at both primary and metastatic sites.

Macrophages also release VEGF, HGF,
MMP2 and IL-8 that influence endothelial cell behaviour and ultimately
stimulate the formation of blood vessels. Neutrophils are also stimulators of
angiogenesis. Additional immune cells do not play much important role in
carcinogenesis . They are not consistent residents of the stroma  and they are restricted to only specific
types of cancer.

 

 

  

   

 

 

 

 

VASCULAR ENDOTHELIAL
CELLS

Angiogenesis is the physiological process
through which new blood vessels form from pre-existing vessels. For cancer cell
growth angiogenesis is important because it supplies nutrients and oxygen which
is needed for tumour growth. Many components of stroma are responsible for
initiation of angiogenesis out of CAFs play an important role in synchronizing
events of angiogenesis by secretion of many ECM molecules and growth factors
such as TGF-?,
VEGF, fibroblast growth factor. It also secretes SDF-1 where SDF-1 signalling
is responsible for recruiting endothelial progenitor cells (EPCs) into the
tumour stroma to form new blood vessels known as vascular mimicry. CAFs also
produce a significant amount of SPARC ( secreted protein and rich in cysteine)
responsible for the regulation of angiogenesis. CAFs also secrete many MMPs
which  causes the  initiation of angiogenesis by the degradation
of the basement membrane,  sprouting of
endothelial cells, regulation of pericyte attachment. As the tumour grows
rapidly there are increased chances of intratumoral hypoxia which promotes
angiogenesis by the production of many secreted factors such as
hypoxia-inducible factors , angiopoietin 1, angiopoietin 4, placental growth
factor, platelet-derived growth factor B. However, these neoangiogenic vessels
are non-uniformly distributed, irregularly shaped, inappropriately branched,
tortuous often ending blindly. These do not have the classical hierarchy of
arterioles, capillaries, venules and oten have arteriovenous